enVVeno Medical (NVNO) Competitors $4.87 +0.26 (+5.64%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.88 +0.00 (+0.10%) As of 08/1/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. RXST, OM, SNWV, STIM, CLPT, CATX, NPCE, NNOX, NYXH, and DRTSShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include RxSight (RXST), Outset Medical (OM), Sanuwave Health (SNWV), Neuronetics (STIM), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), NeuroPace (NPCE), Nano-X Imaging (NNOX), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors RxSight Outset Medical Sanuwave Health Neuronetics ClearPoint Neuro Perspective Therapeutics NeuroPace Nano-X Imaging Nyxoah Alpha Tau Medical RxSight (NASDAQ:RXST) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Which has preferable valuation & earnings, RXST or NVNO? enVVeno Medical has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$139.93M2.27-$27.45M-$0.67-11.64enVVeno MedicalN/AN/A-$21.82M-$1.18-4.13 Do analysts rate RXST or NVNO? RxSight currently has a consensus target price of $17.50, suggesting a potential upside of 124.36%. Given RxSight's stronger consensus rating and higher possible upside, equities research analysts plainly believe RxSight is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 2 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.91enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders hold more shares of RXST or NVNO? 78.8% of RxSight shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 9.6% of RxSight shares are owned by company insiders. Comparatively, 16.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is RXST or NVNO more profitable? enVVeno Medical has a net margin of 0.00% compared to RxSight's net margin of -17.90%. RxSight's return on equity of -9.54% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-17.90% -9.54% -8.51% enVVeno Medical N/A -54.13%-50.92% Does the media favor RXST or NVNO? In the previous week, RxSight had 35 more articles in the media than enVVeno Medical. MarketBeat recorded 38 mentions for RxSight and 3 mentions for enVVeno Medical. RxSight's average media sentiment score of 0.05 beat enVVeno Medical's score of -0.28 indicating that RxSight is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 2 Very Positive mention(s) 0 Positive mention(s) 34 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral enVVeno Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, RXST or NVNO? RxSight has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500. SummaryRxSight beats enVVeno Medical on 11 of the 15 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$80.84M$6.70B$5.48B$9.54BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-4.0620.9428.8623.83Price / SalesN/A54.12371.4566.14Price / CashN/A20.5035.4557.96Price / Book2.034.468.265.54Net Income-$21.82M$174.54M$3.25B$259.28M7 Day Performance-1.81%-5.27%-3.75%-4.67%1 Month Performance23.29%-3.94%4.27%4.37%1 Year Performance-5.62%8.26%25.85%17.91% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.3617 of 5 stars$4.87+5.6%N/A-8.6%$80.84MN/A-4.0630News CoverageEarnings ReportGap UpRXSTRxSight3.3687 of 5 stars$7.83-0.5%$17.50+123.5%-82.4%$318.19M$148.31M-11.69220Trending NewsUpcoming EarningsOMOutset Medical1.7102 of 5 stars$17.54-2.8%$29.50+68.2%-71.4%$310.84M$115.27M-0.60520Upcoming EarningsSNWVSanuwave Health2.2756 of 5 stars$34.76-2.8%$49.00+41.0%N/A$297.89M$32.63M-7.6340News CoverageAnalyst ForecastAnalyst RevisionSTIMNeuronetics1.5458 of 5 stars$4.47-1.1%$5.50+23.0%+148.3%$295.51M$74.89M-3.41180Upcoming EarningsGap DownCLPTClearPoint Neuro2.6744 of 5 stars$10.55-3.8%$25.00+137.0%+47.1%$295.28M$32.24M-13.88110Analyst ForecastGap DownCATXPerspective Therapeutics2.3993 of 5 stars$3.92-4.9%$12.56+220.3%-72.5%$290.97MN/A0.0070News CoverageNPCENeuroPace3.2591 of 5 stars$8.78+0.5%$17.00+93.6%+24.5%$287.98M$84.31M-10.45170News CoveragePositive NewsNNOXNano-X Imaging2.3725 of 5 stars$4.89-4.9%$9.50+94.3%-41.1%$282.54M$11.55M-5.43190News CoverageGap DownNYXHNyxoah2.594 of 5 stars$7.48+4.3%$14.50+93.9%-12.7%$254.77M$4.36M-3.51110Upcoming EarningsGap UpDRTSAlpha Tau Medical2.1138 of 5 stars$2.90-3.3%$8.00+175.9%+43.3%$245.98MN/A-6.3080Positive News Related Companies and Tools Related Companies RXST Alternatives OM Alternatives SNWV Alternatives STIM Alternatives CLPT Alternatives CATX Alternatives NPCE Alternatives NNOX Alternatives NYXH Alternatives DRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
